D
Lineage Cell Therapeutics, Inc. LCTX
$1.27 $0.0958.12% AMEX
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 2.77M 1.50M 2.87M 3.78M 1.41M
Total Other Revenue -- -- -- -- --
Total Revenue 2.77M 1.50M 2.87M 3.78M 1.41M
Cost of Revenue 3.15M 2.98M 3.58M 3.21M 2.91M
Gross Profit -380.00K -1.48M -709.00K 570.00K -1.50M
SG&A Expenses 4.56M 4.86M 4.40M 4.41M 4.36M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 7.71M 8.01M 7.98M 7.62M 7.28M
Operating Income -4.94M -6.51M -5.11M -3.84M -5.87M
Income Before Tax -30.36M -4.14M -3.25M -3.00M -5.77M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -30.36M -4.14M -3.25M -3.00M -5.77M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -100.00K 4.00K -23.00K -33.00K 13.00K
Net Income -30.46M -4.14M -3.27M -3.03M -5.76M
EBIT -4.94M -6.51M -5.11M -3.84M -5.87M
EBITDA -4.77M -6.34M -4.96M -3.70M -5.73M
EPS Basic -0.13 -0.02 -0.01 -0.02 -0.03
Normalized Basic EPS -0.04 -0.01 -0.01 -0.01 -0.02
EPS Diluted -0.13 -0.02 -0.01 -0.02 -0.03
Normalized Diluted EPS -0.04 -0.01 -0.01 -0.01 -0.02
Average Basic Shares Outstanding 228.36M 226.05M 240.19M 188.84M 188.81M
Average Diluted Shares Outstanding 228.36M 226.05M 240.19M 188.84M 188.81M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --